Amneal Pharmaceuticals, Inc.

Develops & commercializes essential medicines: generics, injectables & specialty drugs.

AMRX | US

Overview

Corporate Details

ISIN(s):: US03168L1052
LEI:
Country:: United States of America
Address:: 0
Website:: https://amneal.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Amneal Pharmaceuticals, Inc. is a fully-integrated global biopharmaceutical company engaged in the development, manufacturing, and commercialization of essential medicines. Its diverse portfolio features over 280 products, including generics, injectables, and specialty branded pharmaceuticals. The company operates through a robust generics business and a growing specialty division, with a strategic focus on complex medicines. Key therapeutic areas include oncology and central nervous system disorders like Parkinson's disease, complemented by public health initiatives to increase access to treatments such as Naloxone. A core competency is the development of first-to-file and first-to-market products, aiming to make quality healthcare more accessible and affordable for patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Amneal Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Amneal Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Amneal Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Lyell Immunopharma, Inc. Develops durable CAR T-cell therapies for solid tumors & blood cancers by reprogramming T-cells.	United States of America	LYEL
Lyra Therapeutics, Inc. Developing localized, long-acting therapies for chronic rhinosinusitis (CRS).	United States of America	LYRA
Lytix Biopharma AS Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.	Norway	LYTIX
MaaT Pharma Developing gut microbiome therapies to improve survival for cancer patients.	France	MAAT
Mabion S.A. Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.	Poland	MAB
MACROGENICS INC Biopharma firm developing innovative antibody-based therapeutics for cancer treatment.	United States of America	MGNX
MADRIGAL PHARMACEUTICALS, INC. Develops and delivers the first FDA-approved treatment for the liver disease MASH.	United States of America	MDGL
Magle Chemoswed Holding AB A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.	Sweden	MAGLE
Mainz BioMed N.V. Develops at-home diagnostic tests for the early detection of life-threatening cancers.	Germany	MYNZ
MAINZ BIOMED N.V. Develops molecular genetic diagnostic tests for early colorectal cancer detection in the US & Europe.	United States of America	MYNZ